TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 161 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2016. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $255,000 | -21.1% | 3,547 | -19.1% | 0.00% | – |
| Q1 2021 | $323,000 | +18.8% | 4,384 | -1.3% | 0.00% | – |
| Q1 2020 | $272,000 | -76.6% | 4,440 | -66.4% | 0.00% | -100.0% |
| Q4 2019 | $1,163,000 | +301.0% | 13,226 | +290.1% | 0.00% | +100.0% |
| Q2 2019 | $290,000 | +21.3% | 3,390 | +20.1% | 0.00% | 0.0% |
| Q4 2018 | $239,000 | -36.4% | 2,822 | -21.3% | 0.00% | 0.0% |
| Q4 2017 | $376,000 | +4.4% | 3,588 | +10.2% | 0.00% | -50.0% |
| Q3 2016 | $360,000 | -66.7% | 3,256 | -56.1% | 0.00% | -60.0% |
| Q2 2016 | $1,081,000 | +89.3% | 7,423 | +86.2% | 0.01% | +66.7% |
| Q1 2016 | $571,000 | -58.9% | 3,987 | -55.8% | 0.00% | -78.6% |
| Q3 2014 | $1,389,000 | +125.5% | 9,028 | +105.7% | 0.01% | +75.0% |
| Q2 2014 | $616,000 | -38.9% | 4,389 | -51.7% | 0.01% | -27.3% |
| Q1 2014 | $1,008,000 | – | 9,081 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Claret Asset Management Corp | 94,031 | $10,164,000 | 2.02% |
| ALTERNA WEALTH MANAGEMENT, INC | 20,530 | $2,219,000 | 1.88% |
| Strategic Global Advisors, LLC | 72,308 | $7,816,000 | 1.64% |
| Analyst IMS Investment Management Services Ltd. | 28,438 | $3,074,000 | 0.95% |
| Freestone Capital Holdings, LLC | 129,757 | $14,025,000 | 0.83% |
| Hudson Capital Management LLC | 12,394 | $1,339,667,000 | 0.82% |
| FORT, L.P. | 19,158 | $2,071,000 | 0.42% |
| MENTA CAPITAL LLC | 6,880 | $744,000 | 0.32% |
| Empirical Finance, LLC | 9,511 | $1,028,000 | 0.26% |
| ALGERT GLOBAL LLC | 4,071 | $440,000 | 0.25% |